The 12th International Symposium on Hodgkin Lymphoma (ISHL12) took place as a hybrid conference in Cologne, Germany, from October 22 to 24, 2022. During the conference, ISHL12 provided a comprehensive overview of the latest advances in biology, clinical research, diagnostics and treatment of Hodgkin Lymphoma. The main focus was on older and frail patients as well as on patients with early stage disease. Several workshops, interactive case discussions and satellite symposia complemented the program.
(BELG J HEMATOL 2022;13(8):328–32)